Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Urol Oncol. 2019 Jul 18;38(3):105–117. doi: 10.1016/j.urolonc.2019.06.018

Table 1.

Recommendations on individual diet and lifestyle factors for patients with localized and advanced prostate cancer.

Localized prostate cancer Advanced prostate cancer
Dietary factors
Lycopene/tomato products*** [1719] [20]
Green tea** [9, 10]
Avoidance of non-prescribed vitamin and mineral supplements (e.g., selenium)** [51,52]
Coffee*
Cruciferous vegetables*
Fish*
Larrea tridentata*
Mushrooms*
Vegetable-derived fats*
Avoidance of dairy*
Avoidance of eggs*
Avoidance of poultry with skin*
Avoidance of processed red meat*
Avoidance of saturated fat*
Milk thistle [55]
Pomegranate [32] [33, 34]
Soy [19, 3741] [4244]
Omega-3 fatty acids [17, 2830]
Lifestyle factors
Pelvic floor muscle training**** [6468, 71]
Pilates*** [71]
Exercise**** [7678, 85, 86, 88] [76, 78, 79, 8189]
Healthy body mass index
Smoking cessation
Guided imagery/progressive muscle relaxation*** [97]
Qigong** [99]
Massage** [98]
Acupuncture*
Hypnosis [94]

= Citations are provided for factors with RCTs with a placebo/usual care control group in patients with localized (including post-radical prostatectomy/radiation therapy) and advanced prostate cancer (including patients on androgen deprivation therapy).

Absence of * = Equivocal benefit based on available evidence

*

= Evidence leans toward potential benefit based on at least one observational study or RCT without a placebo control arm

**

= Evidence leans toward potential benefit based on at least one placebo-controlled RCT, but clinical significance is modest

***

= Evidence leans toward potential benefit based on at least one placebo-controlled RCT with clinically significant effect

****

= Well-established benefit based on two or more placebo-controlled RCTs with clinically significant effect

= Overwhelming observational evidence suggests benefit despite lack of RCTs focused on this factor alone.